Insights on R&D innovation, emerging technologies, competitive strategy, and strategic decision-making.
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross...
Electrochromic glass has been “commercially proven” for over thirty years, and it still fails in real-world conditions. That tension sits...
The two largest innovation clusters in leather alternatives are waterborne PU and solvent-free reactive PU, and together represent 32% of...
44% of the global pigment market is now anchored in the Asia-Pacific. Merck Surface Solutions and BASF Colors & Effects...
Global EV sales crossed 20 million units in 2025 and are projected to reach 23 million in 2026, bringing EVs...
Biodegradable EPS alternatives are moving from material substitution to scale-ready packaging systems. The pressure is clear: EPS packaging is still...
Right now, the industry operates on the assumption that consumer experience is the primary barrier to market expansion. As a...
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical study confirmed that low-molecular-weight peony...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was straightforward: who had the purest...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross the stratum corneum. One study...
Over 90% of products marketed as “probiotic” cosmetics contain no live microorganisms. Instead, they deliver postbiotics lysates, ferments, metabolites without disclosing this substitution to consumers...
Around 12% of U.S. adults have used a GLP-1 drug such as semaglutide, tirzepatide, or a similar medication, and about 6% are using one today....
More than 35% of new skincare launches in 2024 used probiotics, prebiotics, or postbiotics. Barrier repair and hydration made up about 41% of microbiome cosmetic...
Over 40% of 2024 skincare launches featured microbiome-related ingredients. Yet approximately 90% of products labeled as “probiotic” actually contain postbiotics (ferments, lysates, filtrates) with no...
Cosmetic R&D teams are being asked to build skin microbiome portfolios while one core question remains unresolved: do barrier repair products need live bacteria, or...
An estimated 15 million U.S. adults currently use GLP-1 receptor agonist medications such as semaglutide and tirzepatide, with that figure projected to reach 30 million...
Precision fermentation is moving from early technical promise to commercial scale-up. GFI notes that fermentation-enabled protein production has expanded from a niche area into a...
Get a demo and explore how leading R&D teams use Slate to streamline discovery, stay ahead of competitors, and drive innovation.
